UTI: extended-spectrum penicillins linked to trimethoprim resistance

  • Mulder M & al.
  • Eur J Clin Microbiol Infect Dis
  • 7 Sep 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Use of extended-spectrum penicillins is associated with trimethoprim resistance in urinary tract infections (UTIs).
  • The mechanism is unclear but may be due to selection by coresistance.
  • Nitrofuran derivatives are associated with lower odds of trimethoprim resistance.

Why this matters

  • Consider coresistance when prescribing antibiotics.
  • Incorporate resistance testing into overall management for patients with recurrent UTIs.

Key results

  • 1264 patients, 80.0% (1011) women; median age, 75.3 (range, 66.5-83.3) years.
  • 31.1% (393) Escherichia coli isolates were trimethoprim-resistant.
  • 70.6% (893) participants were prescribed ≥1 beta-lactam during the study period, including sulfonamide and trimethoprim (58.9%), fluoroquinolone (39.9%), nitrofurantoin (47.7%).
  • Multivariate:
    • >3 extended-spectrum penicillin prescriptions associated with trimethoprim resistance (OR, 1.68; 95% CI, 1.10-2.55).
    • >3 trimethoprim/sulfonamide prescriptions significantly associated with trimethoprim resistance (OR, 2.22; P<.05>
    • >3 nitrofurantoin prescriptions significantly associated with lower frequency of trimethoprim resistance (OR, 0.60; P<.05>
    • Time since last extended-spectrum penicillin prescription associated with trimethoprim resistance (1-3 months; OR, 2.86; 95% CI, 1.29-6.34), except for penicillin/enzymes combinations.

Study design

  • Nested case-control study evaluating effects of prior antimicrobial drug prescriptions on trimethoprim resistance in UTI among Rotterdam (the Netherlands) patients with E coli UTI.
  • Funding: None disclosed.

Limitations

  • Adherence data missing.
  • Residual confounding.
  • Inability to confirm results by genetic association.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit